| Views | |
|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 68 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma | 1 | 2 | 2 | 0 | 16 | 3 | 0 |
| Views | |
|---|---|
| 2024_Rieke_etal.pdf | 37 |
